The study, published in Frontiers in Neuroscience by Guodong Wang and Shuang Wu of Guizhou Medical University, is a comparative bibliometric mapping review of four neuromodulation modalities: transcranial magnetic stimulation (TMS), transcranial direct current stimulation (tDCS), transcranial focused ultrasound and related low-intensity ultrasound stimulation (tFUS/TUS/LIFU), and temporal interference stimulation (TI). Drawing on more than 53,000 records from the Web of Science Core Collection and Scopus published between January 2017 and June 2026, the team applied deduplication, relevance screening, targeted re-auditing, and strict corpus quality control, ultimately retaining 32,017 records. Of these, 20,179 concerned TMS, 10,576 tDCS, 1,100 tFUS/TUS/LIFU, and only 162 TI. After narrowing the ultrasound corpus to a strict neuromodulation core of 843 records — excluding blood–brain barrier opening, drug delivery, ablation, and imaging work — the final comparative dataset contained 31,760 publications.

The growth statistics tell a story of two scientific worlds operating at entirely different scales. TMS, which uses electromagnetic induction to activate cortical neurons and has accumulated decades of clinical evidence including treatment guidelines for depression, grew from 1,547 publications in 2017 to 2,740 in 2025 — an absolute increase of 1,193 papers per year. tDCS, which modulates neuronal resting membrane potentials with weak direct current, added 722 annual publications over the same period. Temporal interference stimulation, by contrast, went from a single paper in 2017 — the year the technique was introduced — to 54 in 2025. That yields a compound annual growth rate of 64.6 percent, the fastest of the four modalities, yet the smallest absolute gain: just 53 additional publications. tFUS/TUS/LIFU occupied an intermediate position, rising from 16 to 176 annual publications with a 35.0 percent growth rate.

This contrast between relative and absolute growth matters because raw percentages can be deceptive when a field starts from a baseline of one paper. The authors explicitly caution that TI’s normalized growth is sensitive to this small-base effect. But the analysis went considerably further than counting papers. Using a size- and year-matched resampling procedure repeated 10,000 times, the researchers sampled 162 records from each comparison modality, matching TI’s year-by-year publication distribution, and then compared six indicators spanning geography, collaboration, and thematic vocabulary.

The most robust finding to emerge from this statistical gauntlet concerned thematic structure. TI showed lower author-keyword Shannon diversity and higher Top-10 keyword concentration than matched samples from TMS, tDCS, and strict-core tFUS/TUS/LIFU, with all six thematic comparisons remaining significant after joint Benjamini–Hochberg false discovery rate correction. In plain terms, TI research revolves around a narrow cluster of technical themes — temporal interference, non-invasive deep brain stimulation, electric fields, computational modeling, and human stimulation — whereas the TMS and tDCS literatures sprawl across depression, stroke, motor cortex, plasticity, and rehabilitation. The ultrasound field showed a mixed profile, blending acoustic engineering foundations with emerging disease-oriented terms such as Alzheimer’s disease, epilepsy, and Parkinson’s disease.

Crucially, this thematic concentration survived every robustness check the authors threw at it. The pattern held when comparator corpora were expanded after record-level adjudication, when inclusion was restricted to title-defined records alone, when the historical title-term procedure was applied to the contemporary datasets, and when the six thematic comparisons were recalculated with two-sided empirical tests. A stratified manual audit of 500 records, independently cross-checked with 96.7 percent agreement and a Cohen’s kappa of 0.902, confirmed that modality-core records constituted the majority of each dataset. TI’s greater focus, in other words, is not an artifact of database quirks or small-sample noise — it is a genuine structural feature of the field.

Yet the deepest insight of the study came from a complementary analysis that inverted the usual logic. Rather than comparing all four modalities over the same calendar window, the researchers aligned each field to its own first nine years: TMS from 1985 to 1993, tDCS from 2000 to 2008, tFUS from 2010 to 2018, and TI from 2017 to 2025. After equalizing corpus sizes through rarefaction to 76 records, the expected pattern — young fields being narrowly focused, mature fields being diverse — did not appear. Instead, early TMS and tDCS were more thematically concentrated than TI, while early tFUS was the least concentrated of all. The relationship between field age and thematic breadth is not monotonic, and this non-monotonic ordering persisted even after the historical tFUS corpus was broadened to include core-adjacent records.

The practical implication is significant: thematic concentration should not be read as a direct proxy for bibliometric maturity, and the historical development of TMS and tDCS cannot be assumed to provide a default roadmap for TI. The TI field, despite its compact size, is already doing things that a naive maturity model would place far in the future. Recent TI research includes direct human deep-target validation — studies stimulating the hippocampus and striatum, some with intracranial or depth-electrode recordings — and investigations in patient populations with Parkinson’s disease and epilepsy, alongside several registered clinical trials in major depressive disorder, bipolar depression, and drug-resistant epilepsy. The authors note these registrations illustrate ongoing translational activity rather than evidence of clinical efficacy.

The co-citation analysis adds another layer to the picture. After canonicalizing cited references to reduce fragmentation from formatting inconsistencies, the four networks displayed distinct intellectual foundations: TI centered on a limited set of biophysical, modeling, dose-optimization, and human-validation papers, with the 2017 Cell paper introducing temporally interfering electric fields standing as its most cited core document at 720 Web of Science citations. TMS’s knowledge base, by contrast, is anchored by evidence-based treatment guidelines with more than 1,700 citations and landmark clinical trials, including the THREE-D and Stanford neuromodulation therapy studies in depression. Geographically, TMS and tDCS involve 112 and 102 contributing countries respectively, compared with 41 for strict-core ultrasound and 29 for TI — yet TI’s multiple-country publication ratio of 25.6 percent actually exceeds those of the larger fields, signaling disproportionate international engagement for so young a literature.

The authors conclude that the four modalities occupy distinct positions on what they call a bibliometric knowledge-structure spectrum, shaped by historical depth, publication volume, technical traditions, and translational pathways rather than by a single developmental axis. For the established fields, the challenge ahead is improving quality and reproducibility within enormous diversified evidence bases. For TI, priorities include multicenter collaboration, standardization of stimulation parameters and electric field modeling, terminology convergence — the field still juggles TI, TIS, tTIS, and other labels — and the shift from proof-of-concept demonstrations toward adequately powered controlled patient cohorts testing dose–response relationships, safety, and clinically meaningful efficacy. Whether temporally interfering electric fields can deliver reliable, selective modulation of deep brain structures remains to be established. But this sweeping map of the literature makes clear that the next chapter of non-invasive deep brain stimulation is already being written faster than almost anyone expected.

Subject of Research: Comparative bibliometric analysis of temporal interference stimulation, TMS, tDCS, and transcranial focused ultrasound for non-invasive brain stimulation

Article Title: Across established non-invasive neuromodulation and emerging deep-targeting strategies: a comparative bibliometric analysis of TI, TMS, tDCS, and tFUS/TUS/LIFU

Article References: Wang, G., & Wu, S. (2026). Across established non-invasive neuromodulation and emerging deep-targeting strategies: a comparative bibliometric analysis of TI, TMS, tDCS, and tFUS/TUS/LIFU. Frontiers in Neuroscience, 20, Article 1922512. https://doi.org/10.3389/fnins.2026.1922512

Image Credits: AI Generated

DOI: 10.3389/fnins.2026.1922512

Keywords: non-invasive brain stimulation, temporal interference stimulation, transcranial magnetic stimulation, transcranial direct current stimulation, transcranial focused ultrasound, bibliometric analysis, deep brain stimulation, neuromodulation, Shannon diversity, temporal interference, co-citation analysis, clinical translation

The rationale for targeting the PCC rests on a substantial body of neuroimaging work. The PCC is a primary hub of the default mode network (DMN), the constellation of regions most active during self-referential thought, rumination, and mind-wandering. Heightened PCC activity has been linked to getting caught up in one’s experience, whereas reduced activity accompanies states of effortless awareness reported by seasoned practitioners. Experienced meditators can willfully dampen PCC activity, and this control is associated with increased anticorrelation between the DMN and the central executive network (CEN), which supports top-down regulation of internal mentation. The Arizona team reasoned that directly suppressing the PCC with ultrasound during training might help novices bypass the hardest early hurdle of meditation: quieting the restless, self-absorbed chatter that derails so many beginners.

Transcranial focused ultrasound is uniquely suited to this challenge. Unlike transcranial magnetic stimulation or transcranial electrical stimulation, tFUS can reach subcortical and midline structures with millimeter-scale precision, because acoustic energy passes through the skull and can be focused at depth. Previous work by the same group showed that PCC-targeted tFUS reduced functional connectivity across the midline of the default mode network, increased state mindfulness, and altered participants’ sense of self and time. Other studies have reported reductions in depression and anxiety symptoms after ultrasound neuromodulation of other targets, including the amygdala. In the new trial, the researchers selected a 5 percent duty cycle based on prior evidence of its suppressive effects, and they individualized the target for each participant by identifying the peak default-mode voxel within the PCC using independent component analysis of that person’s own resting-state fMRI data.

The trial enrolled meditation-naive adults recruited from the Tucson area. Of 214 individuals screened by telephone, 34 were eligible and 30 were randomized to active or sham stimulation; 24 completed the full protocol, with 16 in the active group and 8 in the sham group. Participants completed six laboratory visits, two MRI sessions, 14 daily at-home meditation lessons, and six days of ecological momentary assessment. The training protocol was the same Body Focus program used in earlier dismantling trials of mindfulness training: participants learned to monitor bodily sensations as they arise and pass, noting qualities such as pressure, warmth, or tingling, while maintaining an accepting, non-interfering orientation toward whatever they noticed. Lessons were delivered as standardized audio recordings sent by text message each day, and participants who missed more than three sessions were dropped from the study.

During four in-person sessions, participants meditated with their eyes closed while a technician held a 55-millimeter focused ultrasound transducer against the scalp, coupled with transmission gel and guided by neuronavigation. Active stimulation lasted five minutes; for sham participants, the function generator’s oscillators were switched off so no acoustic signal was emitted. Afterward, participants were escorted to a meditation room and invited to sit for as long as they wished, with the duration recorded. No adverse events were reported, and a second susceptibility-weighted MRI scan at the end of the study showed no damage or changes to vasculature. Most sessions produced few or no reported sensations, although the auditory profile of the device proved to be a blinding problem: 13 of 14 active participants reported hearing a beeping or buzzing during stimulation, compared with only 3 of 8 sham participants, who most likely heard only the amplifier switching on.

The headline neural result was a significant Condition by Session interaction in resting-state DMN-CEN connectivity, measured with functional MRI before and after the training period. In the active group, connectivity between the two networks decreased significantly over the two weeks, while in the sham group the estimated change was a nonsignificant increase. The pattern held at the subnetwork level: all nine DMN-CEN subnetwork interaction estimates were negative, and three survived false-discovery-rate correction. Most compellingly, when the analysis was restricted to connectivity between the stimulated PCC parcel and the central executive network, the decoupling effect was even stronger, with PCC-CEN coupling falling in the active group and rising in the sham group. This seed-based result supports a PCC-mediated mechanism, suggesting the ultrasound directly altered the coordination between the brain’s self-referential machinery and its control systems.

Crucially, the active intervention did not merely accelerate the same trajectory that sham participants followed. The two groups moved in opposite directions, indicating a qualitatively different network reconfiguration induced by combining ultrasound with meditation training. The authors interpret this in light of the inverted U-shaped curve of neural activity that accompanies skill acquisition: novices often show muddled segregation between the DMN and CEN, and early attempts at meditation can even transiently increase self-referential activity as practitioners struggle with mind-wandering. By suppressing the PCC during practice, the stimulation may have helped participants through this initial difficulty, nudging their brains toward the pattern of network segregation seen in long-term meditators, and doing so in only two weeks.

The behavioral findings were more cautious. The preregistered outcome, the total score on the Equanimity Scale-16, did not differ between groups; both active and sham participants gained roughly seven points over the training period. However, an exploratory analysis of the Acceptance subscale revealed that participants with greater decreases in DMN-CEN connectivity showed larger gains in acceptance, an association that was significant within the active group. Average voluntary meditation duration was slightly longer in the active group, about 12 minutes versus 9.5 minutes per session, but the difference was not statistically significant, and the relationship between connectivity change and sitting time differed in direction by condition without reaching significance. The authors are careful to note that reduced DMN-CEN coupling should not be read as unambiguously beneficial: several prior mindfulness interventions have reported increases in positive PCC-prefrontal connectivity, and the direction of meditation-related change in this circuit remains context-dependent across the literature.

The study also carries important limitations that temper enthusiasm. The preregistration called for 80 participants with balanced allocation, but funding and resource constraints reduced the final sample to 24 completers with a 2:1 active-to-sham imbalance, and a post hoc sensitivity analysis showed the trial was powered only to detect very large between-condition differences. The connectivity analyses were treated as exploratory because the preregistered hypothesis did not specify a unique network contrast. Blinding integrity is another concern, given how detectable the active ultrasound was, raising the possibility that expectancy effects influenced self-reported outcomes. The team also notes that no correction for skull-induced acoustic distortion was applied, so some participants may have received suboptimal energy at the target, and future protocols should incorporate CT-based acoustic modeling.

Even with those caveats, the study marks a notable step toward what the authors call a precision wellness approach to contemplative training. Rather than treating meditation as a one-size-fits-all practice, they envision characterizing what each individual needs neurobiologically and behaviorally, then selecting the optimal stimulation target, dose, and exposure to support skill acquisition. If replicated in larger, fully blinded trials with active sham procedures, PCC-targeted ultrasound could become a practical accelerant for mindfulness training, helping beginners reach the network configuration that experienced meditators cultivate over years. For now, the image is tantalizing: a five-minute burst of inaudible sound, aimed at the brain’s self-center, quietly retuning the circuits that determine whether we get swept up in our thoughts or let them pass.

Subject of Research: Transcranial focused ultrasound of the posterior cingulate cortex combined with mindfulness training in meditation-naive adults

Article Title: Facilitating Mindfulness Training with Ultrasonic Neuromodulation

Article References: Lord, B., Lord, E. N., Schachtner, J., Beaman, L., Young, S., Allen, J. J., & Sanguinetti, J. L. (2026). Facilitating Mindfulness Training with Ultrasonic Neuromodulation. Mindfulness. https://doi.org/10.1007/s12671-026-02994-5

Image Credits: AI Generated

DOI: 10.1007/s12671-026-02994-5

Keywords: mindfulness, meditation, transcranial focused ultrasound, posterior cingulate cortex, default mode network, central executive network, equanimity, neuromodulation, functional connectivity, fMRI, brain stimulation, contemplative neuroscience

The research team, led by Ji-Hun Yu, Woong-chang Yoon, Eun-Hee Lee, and Hyeon Seo, working with data from the Alzheimer’s Disease Neuroimaging Initiative, set out to quantify exactly how much modeling error is introduced when non-skull tissues are neglected. Their approach was systematic and unusually comprehensive. Drawing on T1-weighted and T2-weighted magnetic resonance images from twenty cognitively normal adults with a mean age of 65.4 years, the team segmented each head into nine distinct tissue types using the CHARM algorithm from SimNIBS: white matter, gray matter, cerebrospinal fluid, scalp, eyes, compact bone, spongy bone, blood, and muscle. Each tissue was assigned acoustic properties, including speed of sound, density, and attenuation coefficient, drawn from the IT’IS Foundation database, a standard reference in the field.

From these segmentations the researchers built four competing head model configurations of increasing anatomical fidelity. The simplest, designated S, contained only the skull immersed in water, a common approach that treats everything outside and inside the cranium as a homogeneous coupling medium. The second added the scalp, the third added the grouped non-skull soft tissues such as gray matter, white matter, cerebrospinal fluid, blood, eyes, and muscle, and the fourth, the most realistic, included both scalp and soft tissues. Simulations were then run with the open-source k-Wave toolbox, which solves the coupled first-order acoustic wave equations using a k-space pseudo-spectral time-domain method. To keep numerical error in check, the team resampled the MRI data from one-millimeter to 0.6-millimeter resolution, corresponding to roughly ten grid points per wavelength, well above the six points per wavelength generally considered sufficient for acoustic neuromodulation work.

The scale of the computational campaign is one of its distinguishing strengths. A custom single-element focused transducer operating at 250 kilohertz, with a radius of curvature of 110 millimeters and an aperture diameter of 128 millimeters, was positioned at thirteen target sites defined by the international 10-10 electroencephalography system, spanning seven coronal and seven sagittal locations. Each transducer was placed normal to the local skull surface, sixty millimeters away, to minimize aberration from oblique incidence. Multiplying twenty subjects by thirteen positions by four model configurations yielded a total of 1,040 full three-dimensional wave propagation simulations, plus an additional free-water run for each case to normalize the results. Few previous studies have attempted to isolate tissue-layer effects across such a broad matrix of anatomies and stimulation sites.

The headline finding is that the soft tissues matter more than many modelers have assumed. Normalized peak pressures across all conditions ranged from roughly 0.4 to 0.8, meaning the skull and overlying tissues attenuated the beam by 20 to 60 percent relative to free-water propagation. When the researchers compared models with and without the intracranial soft tissues, statistically significant differences in peak pressure appeared at eleven of the thirteen stimulation positions, whereas adding the scalp alone produced significant differences at only six to eight positions. In other words, the brain’s internal anatomy, not just the skull, exerts a measurable influence on how much acoustic pressure reaches the target. The effect was especially pronounced along the sagittal plane, where the propagation path crosses a denser thicket of tissue interfaces, producing reflections and refractions that can either reduce or, counterintuitively, slightly increase the focal pressure depending on the individual and the site.

Focal volume, defined as the region enclosed by the full width at half maximum of the pressure distribution, told a complementary story. Across the stimulation positions it ranged from about 500 to 3,000 cubic millimeters, and models that incorporated the soft tissues generally produced larger, more diffuse focal regions than their skull-only counterparts. This inverse relationship with peak pressure follows directly from the physics: a beam that loses pressure to attenuation and impedance mismatches also spreads its remaining energy over a broader zone. The spatial overlap between focal regions from different model configurations, quantified with an intersection-over-union metric across 1,560 pairwise comparisons, reinforced the pattern. Comparisons differing only in scalp inclusion produced tightly clustered overlap values between 0.70 and 0.98, while comparisons involving the soft tissues dropped to roughly 0.50 to 0.90, indicating that the internal anatomy can shift the very location and shape of the ultrasound focus.

The study also revisited an old question about which anatomical measurements best predict ultrasound delivery. Using the scalp-and-skull model, the team correlated tissue thicknesses, measured within a cylindrical volume aligned with the transducer axis, against simulation outcomes across 260 subject-position pairs. Skull thickness emerged as the strongest predictor, showing a significant negative correlation with peak pressure (r = -0.5334) and a significant positive correlation with focal volume (r = 0.5106), both at p < 0.01. Scalp thickness, by contrast, was only weakly associated with either outcome. Yet when the same correlation analysis was repeated within individual subjects across the thirteen positions, the relationships became statistically inconsistent, appearing clearly in only nine of twenty subjects for peak pressure. The authors attribute this to the crudeness of using a single average thickness value, which cannot capture skull curvature, surface roughness, or the internal heterogeneity of cortical and cancellous bone, and to the limited number of positions per subject.

Why does all of this matter beyond the modeling community? The clinical stakes are considerable. Low-intensity transcranial focused ultrasound is being explored as a noninvasive alternative to deep brain stimulation, avoiding the surgical implants that complicate patient compliance, and it offers millimeter-scale targeting that electromagnetic techniques like transcranial magnetic stimulation cannot match. Dosage in these applications is prescribed in terms of pressure and intensity at the target, so a simulation that overestimates focal pressure, or misplaces the focus by several millimeters, could translate directly into underdosed or misdirected treatment. Earlier work had already hinted at the problem: a study by Slominski and colleagues found that including cerebrospinal fluid in head models could raise the focal absorbed power density by up to 29 percent, and Guo and colleagues estimated that the brain itself contributes roughly 34 percent of total acoustic attenuation, far from negligible compared with the skull’s 83 percent.

The authors are careful to note the limitations of their own approach. All simulations were conducted at 250 kilohertz, a frequency chosen to make 1,040 runs computationally feasible and one that is widely used in clinical and artificial-intelligence-driven tFUS studies. But aberration and attenuation both grow with frequency, so the tissue-layer effects documented here are likely to become more pronounced, not less, at the higher frequencies used in some therapeutic applications. The cohort was also relatively old, with a mean age of 65.4 years, and skull morphology changes with age, so the findings may not fully generalize to younger populations. Fixed literature-based acoustic properties, moreover, cannot capture inter-subject variability, and the sensitivity analysis is sobering: to keep peak pressure error within 5 percent, the speed of sound must be accurate to within 1.75 percent for the skull and 2.5 percent for the scalp.

The practical takeaway is a call for richer, more individualized head models. Because acquiring CT scans purely for research participants raises radiation concerns, many laboratories have turned to MRI-based modeling, and this study suggests that such models gain real fidelity when they explicitly segment and assign properties to the soft tissues rather than collapsing them into water. The ideal future, the authors argue, lies in co-registered CT-MRI datasets that combine CT’s detailed view of skull heterogeneity with MRI’s rendering of intracranial anatomy, supported by experimental validation using multilayered phantoms that mimic the scalp, skull, and brain. Until then, the message for anyone planning a transcranial focused ultrasound experiment or trial is clear: the skull may be the great gatekeeper of cranial acoustics, but the brain behind it is far from acoustically invisible, and treating it as such risks steering the beam away from its intended target.

Subject of Research: Quantitative assessment of how scalp and intracranial soft tissue layers affect transcranial focused ultrasound simulation accuracy

Article Title: Quantitative impact of tissue layer composition in transcranial focused ultrasound modeling

Article References: Yu, J.-H., Yoon, W.-C., Lee, E.-H., & Seo, H. (2026). Quantitative impact of tissue layer composition in transcranial focused ultrasound modeling. Heliyon, 12(15), Article e45487. https://doi.org/10.1016/j.heliyon.2026.e45487

Image Credits: AI Generated

DOI: 10.1016/j.heliyon.2026.e45487

Keywords: transcranial focused ultrasound, neuromodulation, acoustic simulation, k-Wave, skull modeling, MRI segmentation, brain tissue, peak pressure, focal volume, blood-brain barrier, Alzheimer's disease, head modeling

The LUMEN project, led by Dr. Emanuele Riva from the Department of Mechanical Engineering, delves into the forefront of neurostimulation technology through the development of advanced acoustic metamaterials. Its core focus lies in optimizing transcranial focused ultrasound (tFUS), a non-invasive modality increasingly harnessed to treat movement disorders like Parkinson’s disease and essential tremor. One of the paramount challenges in current tFUS applications is the unintended dispersion of “leaky-Lamb waves,” acoustic waves scattered irregularly by the complex barrier of the human skull. These waves diminish the precision and efficacy of ultrasound brain stimulation, limiting clinical outcomes.

To confront this obstacle, LUMEN proposes a pioneering approach that engineers acoustic metasurfaces capable of controlling the emission direction of these leaky-Lamb waves at their source. Acoustic metasurfaces, a class of precisely arranged nanostructures, manipulate the propagation of sound waves through subwavelength scale modifications. By integrating biocompatible implants fashioned with these metasurfaces, the project aims to significantly refine the focal targeting of ultrasound energy. The anticipated effect is twofold: enhanced accessibility of the technology, and a remarkable increase in the precision of stimulation, especially in previously hard-to-reach peripheral brain regions. This advancement may revolutionize treatment protocols for millions suffering from debilitating tremors and neuropathic pain, extending therapeutic benefits to diverse patient profiles.

Dr. Riva’s background in structural dynamics and elastic wave mechanics underpins this ambitious enterprise. Having earned his PhD with honors from Politecnico di Milano, his research portfolio is distinguished by expertise in metamaterials and wave propagation, encompassing vibration control and energy harvesting technologies. His engagement with academic publications and patents, along with co-founding a specialized company in vibrational acoustics, demonstrates a rare blend of fundamental research and entrepreneurial innovation essential for bridging theoretical concepts with clinical applications.

Parallel to LUMEN’s endeavor, the ALFRED project, spearheaded by Dr. Claudio Conci from the Department of Chemistry, Materials, and Chemical Engineering “Giulio Natta,” embarks on a radically novel diagnostic frontier. ALFRED stands for Positron Annihilation Lifetime Spectroscopy for Revealing and Quantifying Inflammation and Endothelial Diseases. It exploits the particle physics technique of Positron Annihilation Spectroscopy (PAS) to detect early-stage inflammatory signatures with unparalleled resolution and non-invasiveness. Inflammation’s stealthy onset often eludes conventional diagnostic tools until manifest symptoms appear, delaying timely intervention in conditions ranging from cancer to neurodegenerative and cardiovascular diseases.

PAS uniquely harnesses the behavior of positrons—antiparticles of electrons—that, upon interacting with electrons in biological tissue, annihilate and emit gamma rays. The timing and spatial characteristics of this emission can reveal microscopic changes in tissues at the molecular and cellular levels. By adapting this technique to medical imaging, ALFRED seeks to quantify localized inflammation with sensitivity far exceeding existing modalities. This fusion of bioengineering, nuclear medicine, and particle physics could reshape preventive healthcare by intercepting disease processes before irreversible damage ensues.

Dr. Conci, whose academic genesis blends biomedical and bioengineering disciplines, has honed his expertise through multidisciplinary collaborations with Italy’s leading research institutes. His career focus on ethical imaging solutions and miniaturized medical diagnostic devices lays the foundation for ALFRED’s integrative methodology. The project exemplifies the translation of fundamental physics into tangible, life-saving medical technologies.

Politecnico di Milano’s distinction as Italy’s prime locus for Horizon Europe funding underscores its strategic role in fostering scientific excellence. Housing 362 projects amounting to over 175 million euros and securing 39 ERC projects worth over 41 million euros, the institution exemplifies leadership in advancing frontier research. The selection of LUMEN and ALFRED among 478 ERC-funded projects in 2025 highlights their exceptional potential to redefine medical engineering paradigms.

ERC Starting Grants fuel early-career researchers who have recently obtained their doctorates but stand at a critical juncture to embark on independent scientific trajectories. The grants encourage audacious, foundational research peering beyond existing knowledge frontiers. Both projects resonate with this mandate, as they challenge established constraints within their respective domains and engage interdisciplinary synergies.

The potential impact of LUMEN extends beyond treating motor symptoms; by enhancing the precision of ultrasound wave focusing via metamaterial engineering, it opens avenues for neuromodulation therapies targeting a broad spectrum of neurological disorders. Its emphasis on affordability and accessibility further ensures that such advanced treatments may reach underserved populations worldwide, addressing health equity issues intrinsic to medical innovation.

Conversely, ALFRED’s promise lies in revolutionizing diagnostics by unveiling invisible biological processes that underpin inflammation—a precursor to numerous chronic and acute conditions. With the capacity to detect molecular perturbations non-invasively and at an early stage, this technology could enable clinicians to devise personalized treatments, optimize therapeutic windows, and ultimately improve prognoses.

Taken together, these initiatives exemplify how convergence science—melding material science, applied physics, bioengineering, and clinical medicine—can surmount longstanding limitations in healthcare. Their anticipated breakthroughs signify a future where non-invasive, precise, and rapid interventions become standard components of disease management, elevating patient care to unprecedented levels.

As the LUMEN and ALFRED projects forge ahead under the Politecnico di Milano umbrella, their trajectories illuminate the vital landscape where technological innovation intersects with urgent societal health needs. Supported by the visionary backing of the European Research Council, these projects embody the transformative potential of early-stage scientific ambition nurtured within world-class research environments.

The collaborative fabric woven through both projects, spanning multiple disciplines and institutions, reflects the modern ethos of scientific inquiry. It is this intersectional approach that fuels novel methodologies—from manipulating acoustic metamaterials at the microscale to applying positron physics in biological systems—ushering in a new era of medical diagnostics and therapeutics backed by precise, physics-based technologies.

In an era increasingly defined by personalized medicine and minimally invasive interventions, the LUMEN and ALFRED projects position themselves front and center as beacon initiatives. They are poised not only to deepen understanding of complex physiological phenomena but also to translate this knowledge swiftly and safely into patient-centered solutions. The coming years will be pivotal in witnessing how these ERC-funded endeavors reshape the sonic and imaging landscapes underpinning essential neurological and inflammatory disease care.

Subject of Research: Acoustic Metamaterials for Focused Ultrasound Neuromodulation; Positron Annihilation Spectroscopy for Inflammation Detection

Article Title: Pioneering Neuromodulation and Inflammation Diagnostics: Politecnico di Milano’s ERC-Funded Breakthroughs in Medical Engineering

News Publication Date: 2025

Web References:
https://mediasvc.eurekalert.org/Api/v1/Multimedia/69a8ade3-3d36-4432-9738-a036ceaebfb6/Rendition/low-res/Content/Public

Image Credits: Claudio Conci

Keywords: Acoustic Metamaterials, Focused Ultrasound, Neuromodulation, Positron Annihilation Spectroscopy, Inflammation Detection, Biomedical Engineering, Structural Dynamics, Particle Physics, Neurodegenerative Diseases, Medical Imaging, Non-invasive Diagnostics, European Research Council